Targeting piroplasmosis and theileriosis: New frontiers in drug development
InfectologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Tropical animal health and production
- Publicado em
- 9 dez 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Targeting piroplasmosis and theileriosis: New frontiers in drug development
Ritika Rajput, Amar Prajapati, Anand Srivastava
Descritores MeSH
- Babesiosis
- Theileriasis
- Antiprotozoal Agents
- Drug Development
- Babesia
- Animals
- Theileria
Veja também
Estudos relacionados
- Next-generation sequencing in tick-borne apicomplexan parasites: approaches for Theileria and Babesia, a systematic review
- The continental distribution of Theileria and Babesia species in African wild mammals: A systematic review and meta-analysis of molecular prevalence
- Systematic Review and Meta-Analysis on Piroplasma spp. Infection and Co-infection with Anaplasma marginale in Domestic Ruminants from Algeria
- Eco-epidemiology of equine piroplasmosis and its associated tick vectors in Europe: A systematic literature review and a meta-analysis of prevalence